Abstract
Methods for grouping specific avian influenza virus (AIV) hemagglutinin (HA) and neuraminidase (NA) subtype reverse-transcription polymerase chain reaction (RT-PCR) products into HA:NA subtypes when egg incubation is technically not feasible were evaluated. These approaches were adopted for use as post hoc methods after melt curve analysis. The methods are based on ratios obtained from amplicon copy count and amplicon molarity and were founded on the premise that infectious particles contain an equal copy count of singlestranded ribonucleic acid segments that encode HA or NA, and thus subtype-specific amplicons from a single AIV isolate should yield a theoretical HA:NA ratio of 1. Single and mixed HA:NA AIV subtype samples were evaluated to determine whether the calculated HA:NA ratios would approach the theoretical value. With these samples, preference was given to the molarity methods to better define and correct for the effects of multiple potential amplicons in the amplification mix. Further, the molarity method was used to evaluate pond sediment spiked with intact virus of known HA:NA subtype to determine whether the method is sufficiently robust to be used with complex samples, such as those acquired from waterfowl habitat. This was a proof-of-concept study intended to guide future methods development. The methods here are not meant to be applied in any other context.
From the analysis of fully characterized isolates of North American AIV, the HA:NA molarity-based ratios were found to be 1.63 ± 0.75 (mean ± standard deviation) when corrected for the difference in amplification strength and the production of multiple amplicons in some reactions using equations developed in this study. Copy count HA:NA ratios, obtained from HA and NA subtype (RT-qPCR), were 1.146 ± 0.124 (mean ± standard deviation) when corrected for amplification efficiency. Correct associations of HA:NA subtype sample composition were made with mixed samples containing 1 HA and 2 NA, and 2 HA and 2 NA. When spiked pond sediment was evaluated, the molar ratio obtained for the H4 and N6 identified in the sample was 1.28 with correction and 1.14 without correction.
Background
Avian influenza virus (AIV) poses global threats to food production from domestic animal and human health (Machalaba and others, 2015) . Consequently, surveillance programs for AIV in waterfowl populations, and recently (2018) environmental reservoirs, are of increasing importance (Lang and others, 2008) . A subset of the known hemagglutinin (HA) subtypes is associated with high pathology AIV (HPAIV). Although changes in HA gene segments are recognized as major components in the transformation of low pathology AIV to HPAIV, changes in neuraminidase (NA) gene segments are also known to contribute to this transformation (Stech and others, 2015) . The role of multiple gene segments in the development of HPAIV emphasizes the importance of recognizing not only individual HA and NA subtypes, but also the combined HA:NA subtypes in AIV surveillance programs.
Our interest is in the direct molecular-based characterization of AIV from environmental samples to the level of HA:NA associated subtypes without the need for virus amplification by cell culture. Typical AIV screening utilizes quantitative polymerase chain reaction (qPCR) methodology that includes the use of subtype-specific TaqMan probes for selected virulent subtypes (Payungporn and others, 2006) . Holistic screening of AIV diversity in the environment may yield a better understanding of viral ecology. Methods that utilize degenerate primers that amplify the full repertoire of known HA and NA subtypes have been developed (Tsukamoto and others, 2012) but are problematic in terms of HA:NA subtype associations. When single HA and NA subtype genes are characterized from a sample, questions remain as to whether additional subtypes have been lost during the isolation and characterization process. When multiple AIV subtypes are present in a sample, the association of HA and NA into specific HA:NA subtypes can be impossible without additional information. Here we suggest an alternative method for HA:NA subtype association that can assist in this process.
TaqMan-and SYBR Green-chemistry methods have been used in combination with reverse transcription quantitative polymerase chain reaction (RT-qPCR) to evaluate samples for the presence of AIV. The former method is effective for diagnostic screening when the exact target AIV subtype is known because the inclusion of a probe increases assay specificity (Payungporn and others, 2006) . The latter method has proven useful for surveillance when used with degenerate primer sets that target all known HA and NA subtype genes, where copy count and melt curve analyses are used to determine specificity (Tsukamoto and others, 2012) . Tsukamoto and others (2012) produced sample-specific HA and NA subtype lists. This product type, produced from PCR-based AIV genome copy detection, is like that obtained using antibodybased AIV protein detection (Bowman and others, 2015) . Product type is the only similarity between these two methods, making direct comparisons of HA and NA subtypes ambiguous. Neither method yields HA:NA subtype associations.
When using TaqMan-chemistry, the grouping of HA and NA subtypes into an HA:NA subtype association occurs by default because only one HA subtype and one NA subtype are targeted using highly specific probes and type-specific methods validation (Payungporn and others, 2006) . Alternatively, nothing may be detected, or a single subtype may be detected resulting in a failed or incomplete analysis. A benefit of probe specificity with TaqMan-chemistry is that it increases outcome confidence but it also limits detection when subtype sequence variation or subtype re-assortment occurs. This limitation makes the method less than ideal for environmental surveillance projects intended to detect sequence variation or subtype re-assortment.
When using intercalating dye chemistries such as SYBR Green and primer sets for multiple HA and NA subtypes, which are degenerate to accommodate type-specific sequence variation (Tsukamoto and others, 2012) , the confidence associated with high probe specificity is exchanged for breadth of the subtype-specific isolate amplification. Unlike the results obtained using TaqMan-chemistry, when SYBR Greenchemistry is used with multiple subtype primers, no means for subtype association into HA:NA grouping is afforded. Detection of multiple HA and (or) NA subtypes in a single sample can make the determination of HA:NA subtypes problematic without additional information. In theory, the subtype copy count could be used to associate subtypes into HA:NA subtypes because the Influenza A genome consists of single copies of the HA and NA genes (Cheung and Poon, 2007) . The copy count ratio of two subtypes that associate to form an HA:NA grouping should approach 1.00. The difficulty with this approach is that validation over a broad range of potential sample mixtures is required. Here, we suggest an alternative solution for the association of HA and NA subtypes into specific HA:NA subtypes and compare the results to results obtained from copy count determinations.
Our alternative approach is a modification of RT-qPCR melt curve analysis (Tsukamoto and others, 2012) using SYBR Green-chemistry and multiple HA and NA primer sets. Applying the same reasoning as used in copy count ratios, we propose the use of molar ratios. Molar ratios are broadly used to describe the composition of complex biomolecules and cellular structures, characterize biochemical interactions, and differentiate normal versus disease states at the subcellular and molecular levels. We are simply applying a classic and well described concept in a different way.
In this proof-of-concept study we evaluated the potential for the practical use of subtype-specific amplicon copy count and molarity in AIV HA:NA subtype association when high throughput sequencing methods are not possible. This approach is applicable to environmental samples containing single or multiple AIV HA:NA groupings. As such, multiple single HA:NA subtypes representing common North American subtypes as well as mixtures of these HA:NA subtypes were evaluated starting with ribonucleic acid (RNA) from fully characterized AIV isolates. As a proof-of-concept, the intent of this study is to inform the development of future methods, and thus the methods here are not meant to be applied in any other context. This report discusses the methods used in the new alternative approach. Results of this approach are presented in tables and figures.
Methods
RNA extracted from characterized isolates of multiple subtypes was provided by U.S. Geological Survey (USGS) Alaska Science Center, Anchorage, Alaska (table 1) (Pearce and others, 2009; Pearce and others, 2010; Ramey and others; 2010a; Ramey and others, 2010b; Pearce and others, 2011; Ramey and others, 2011; Reeves and others, 2013) . Viral RNA was reverse transcribed using the Applied Biosystems high-capacity complementary deoxyribonucleic acid (cDNA) reverse transcription kit (Life Technologies, Carlsbad, California) with random hexamers from the manufacturer's protocol.
All HA and NA subtypes were analyzed on an Applied Biosystems ViiA 7 real-time qPCR (Life Technologies, Carlsbad, Calif.) . PCR with a melt curve analysis was performed as described by Tsukamoto and others (2012) but with modifications. The 20-microliter (µL) reaction mixture contained Applied Biosystems Power SYBR Green PCR Master Mix (Life Technologies, Carlsbad, Calif.), 2 micromoles (µM) of forward and reverse primers (table 2), and 1 µL of cDNA. The cDNA was not normalized prior to amplification nor were starting concentrations measured. The melt curve was used to confirm successful amplification of the correct amplicon using dissociation temperature as described in Tsukamoto and others (2012) . Each reaction was run in duplicate except for the control reactions, which were run in triplicate. Replicates were pooled prior to purification.
Post-amplification product purification was performed using the QIAquick PCR Purification Kit and following the manufacture's protocol (Qiagen, Valencia, Calif.) . All purified RT-qPCR) products were evaluated using an Agilent Bioanalyzer with Expert Software (Agilent Technologies, Santa Clara, Calif.) with Agilent DNA 1000 Kits and following the manufacturer's protocols. Analysis was performed using the default setting, except for height threshold which was reduced to 5 fluorescent units. Potential target amplicons were identified based on maximum observed amplicon molarity determined from subtype-specific reaction products that fell within the assay sensitivity range of 0.1-50 nanograms per microliter (ng µL-1) (Agilent Technologies) and within the size range of 100-400 base pairs (bp; Tsukamoto and others, 2012) . Amplicons from all reactions were sequenced in both directions using Applied Biosystems Big Dye Cycle Sequencing Kit (Foster City, Calif.) to confirm nucleotide sequence. The sequencing reaction profile used consisted of 30 cycles of 20 seconds at 96 degrees Celsius (ºC), 20 seconds at 58 ºC, and 4 minutes at 60 ºC, with a 10-minute extension at 72 °C. The sequencing reactions were cleaned with Agencourt CleanSEQ (Beckman Coulter Genomics, Beckman Coulter Inc., Brea, Calif.), following manufacturer's instructions. Sequencing was carried out on an Applied Biosystems 3130xl Genetic Analyzer (Foster City, Calif.). Biomatters Limited, Geneious R6 software (San Francisco, Calif.) was used to trim and align sequences. Finalized sequences were compared with those published for the specific isolates from which the target amplicons were The copy counts for HA and NA genes in each isolate were quantified using quantitative RT-qPCR. Briefly, RT-qPCR was run using SYBR Green-chemistry with a standard curve for each subtype to calculate the copy count. The RT-qPCR reaction mixture and amplification conditions were the same as those used in melt curve analysis described above. Standards were created using eight dilutions of the purified amplicons from samples of each subtype (table 1) with calculated standard concentrations of 108-101 copies/µL. The relation between HA and NA copy counts from each isolate was evaluated by calculating HA:NA ratios.
Corrected molar ratios were determined using the following equations:
where ABS is absolute value, in nanomoles; H1SAM or N1SAM is specific amplicon molarity of hemagglutinin or neuraminidase subtype under consideration; H1AS or N1AS is amplification strength as measured by total fluorescence at the end of the terminal qPCR cycle of hemagglutinin or neuraminidase subtype under consideration; H1TM or N1TM is total molarity observed for all amplicons, including the subtype-specific amplicon from subtype-specific product analysis of hemagglutinin or neuraminidase subtype under consideration; H2SAM or N2SAM is similar to H1SAM or N1SAM, except that values are those used to correct for the molarity contribution of subtype not considered in ratio; H2AS or N2AS is similar to H1AS or N1AS, except that values are those used to correct for the molarity contribution of subtype not considered in ratio; and H2TM or N2TM is similar to H1TM or N1TM, except that values are those used to correct for the molarity contribution of subtype not considered in ratio. 1 Post-amplification product purification was performed using the QIAquick PCR.
The equations for corrected molar ratios were derived as modifications of the simple HA:NA ratio. Amplification strength was used to correct for the production of non-target amplicons, a phenomenon associated with SYBR Greenchemistry (Wittwer and others, 1997 ) that may have a negative effect on final target amplicon concentrations. The use of total molarity had a similar function correct for the occurrence of non-target amplicons in a size range of 100-1,000 bp. Equations used to calculate corrected molarity when two HA:NA subtypes with a shared HA or NA subtype occurred (eqs. 2 and 3) were developed to account for the molarity of one subtype being divided between two other subtypes. The equation for situations where 1 NA and 2 HA subtypes are detected (eq. 3) is provided, but an example is not presented to avoid redundancy.
Target amplicon molarity was taken from the standard Agilent 2100 Expert software output. Total sample molarity was calculated by obtaining the sum of molarities from each double-stranded DNA sample component that was 100-1,000 bp in size and within the quantitative range of the assay. Amplification strength was determined from qPCR output for each reaction by measuring total fluorescence at the end of cycle 30. Standardized values of amplification strength were determined by dividing 1,000,000 by the reaction-specific fluorescence. In this calculation, amplification strength decreases as the standardized values increase. To facilitate ease of comparison, corrected molar ratios calculated to be between 0.01 and 0.99 were converted to a value greater than 1 by dividing 1 by the calculated value.
Chicken-egg allantoic fluid containing viable H4:N6 virus was used to produce a "spiked" pond sediment. Total RNA was then extracted using a RNA PowerSoil Total RNA Isolation Kit (Mo Bio) and following the manufacture's protocol. Initial virus concentrations were in an expected range of 105-107 virus per milliliter (mL-1) of allantoic fluid (Hon S. Ip, USGS, written commun., 2016). Sediment was obtained from a pond used by overwintering waterfowl and was a mix of silt, sand, and vegetation. Two spiked sediment samples and one negative control sediment sample were evaluated. Each sample and the negative control contained 2.00 ± 0.05 grams (g) of sediment. Total spike volume was 1 mL. The final concentration of the first spike sample was in the range of 105-107 virus per g-1 of sediment. The second spiked sample contained a 1:10 dilution of the first spike with the dilution performed in RNAase-and DNAase-free molecular grade water (NF water). The negative control sample was treated with 1 mL of NF water only. Both alcohol precipitation steps used in the RNA extraction process were performed for 30 minutes at −20 °C. Conversion of extracted RNA to cDNA, RT-qPCR amplification, and analysis of PCR products using the Bioanalyzer were performed as described above. 
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Results and Discussion
Development of these assays was intended to be applied as a post hoc analysis of the Tsukamoto and others (2012) melt curve method. The use of RT-qPCR and molar ratios as described here is strictly intended as a component in the characterization of environmental samples that are evaluated using molecular methods only. Fragment size analysis provides confirmation of amplicon size and an opportunity to determine molar ratios in the presence of multiple HA:NA subtypes in a single sample. AIV genomic RNA from egg culture was used to validate the suggested method.
Subtype-specific sequence data (table 3) for potential target amplicons were consistent with the published data for the isolates from which the amplicons were produced (table 4).
Isolate specific copy count HA:NA ratios obtained from HA and NA subtype RT-qPCR were 1.146 ± 0.124 (mean ± standard deviation). Ratio values ranged from 1.028 to 1.509. Statistical metrics for the RT-qPCR, including amplification efficiency (table 5) and isolate specific subtype copy counts (table 6), are provided. Electropherograms for HA ( fig. 1) and NA (fig. 2) , including amplicon size and molarity values, are typical of Bioanalyzer DNA 1000 chip output when evaluated using Agilent 2100 Expert software to compare amplicons with the included standard ladder. Based on the ladder as the sample, the Agilent DNA 1000 performance metrics are as follows (Agilent Technologies): sizing accuracy of ± 10 percent, a sizing reproducibility of 5-percent cumulative variance (CV), quantitation accuracy of 20 percent CV, and quantitation reproducibility Figure 1 . Typical electropherograms hemagglutinin subtypes evaluated in this study as produced by Agilent's Bioanalyzer DNA 1000 and Agilent's 2100 Expert software. Analyses produced from purified and characterized isolates reverse transcribed into deoxyribonucleic acid from purified ribonucleic acid, amplified by reverse transcription quantitative polymerase chain reaction, and then evaluated for amplicon size and molarity. Subtype identification is associated with each graph.
(bp, base pair; FU, fluorescent unit; H, identifies hemagglutinin gene; IM, internal marker; TA, subtype-specific target amplicon) Table 6 . Copy count of hemagglutinin and neuraminidase genes obtained from gene copy counts present in the ribonucleic acid from avian influenza virus isolates used in this study, as determined by quantitative real-time reverse transcription polymerase chain reaction.
[ of 15 percent CV within the 25-500 bp range. Reactions involving a single HA:NA subtype produced a single amplicon in most of the amplifications. In reactions that did exhibit multiple amplicons, the products were less than 100 bp in size and thus outside the expected range for the desired amplification products.
Results of analysis of amplicon size indicate that the primary product of reactions involving a single HA:NA grouping and targeting a single HA or NA subtype could vary considerably from published values (table 7; Tsukamoto and others, 2012) . Target amplicons that varied from published values by more than 10 bp were all smaller than the published values and were mostly HA subtypes, except for N6. Departures from published values tended to increase with increasing amplicon size (data not shown). Calculated standard deviations of amplicon sizes were all low, ranging from 1 to 3.
Corrected molar ratios (eq. 1) obtained for 36 isolates from 13 HA:NA subtypes had a mean ± standard deviation (SD) of 1.63 ± 0.75. Corrected molar ratio calculations produced values (table 8) closer to theoretical perfect value of 1 relative to the simple HA:NA ratio for 22 of the 32 isolates with an improvement toward 1 of 4.50 ± 7.70 (mean ± SD) relative to the simple HA:NA ratio. In the 10 cases where the simple ratio produced values closer to the ideal value of 1, improvement relative to the corrected molar ratio was 0.30 ± 0.36. In HA:NA subtypes for which there were at least four isolates analyzed, corrected molar ratio mean ± standard deviation values were as follows: H1:N1 1.74 ± 0.13, H3:N8 1.41 ± 0.42, H4:N6 1.12 ± 0.07, H5:N2 2.67 ± 1.15.
In mixed samples containing two HA:NA types ( fig. 3) , the lowest corrected molar ratios (eq. 2) created subtype associations of H3:N8 and H4:N6 (table 9) , which accurately reflect the types included in the equation. The H4:N6 combination exhibited the lowest corrected molar ratio (1.09). The H3:N8 combination had a lower ratio (2.03) than the alternative H3:N6 (2.13), indicating that, from an H3 perspective, H3:N8 would be a more viable combination. Pairings are based on the closest fit to the ideal value of 1.00. The combinations of H3:N8 and H4:N6 provide the closest fits for the two HA:NA pairing. Single-size appropriate amplicons were recognized in each of these reactions. The corrected molar ratio for H4:N6 was very close to the mean value for H4:N6 isolates evaluated as a single HA:NA subtype. The actual isolate used in this mix, isolate 49090, ( 
1 Value rounded to nearest whole number. Actual amplicon sizes provided for H6.
2 From Tsukamoto and others, 2012; based on amplicon mean size.
3 Mean and standard deviation not determined; 363 used in applicable comparisons. Table 8 . Corrected HA:NA subtype-specific molar ratios determined for amplicons from purified and characterized isolates of avian influenza virus reverse transcribed into cDNA from purified RNA. Table 9 . Results from a mixed sample containing two avian influenza virus HA:NA subtypes. Mix produced from purified ribonucleic acid extracted from characterized isolates of avian influenza virus which was reverse transcribed into deoxyribonucleic acid, amplified by quantitative polymerase chain reaction, and then evaluated for amplicon size and molarity.
[ (table 8) .
A second mixed sample containing two HA:NA subtypes was evaluated (fig. 4) . In this mix, only three subtypes were present (H4, N6, N7), requiring the use of a different equation for calculating corrected molar ratios (eq. 3). Here, where H4 was the only HA subtype, the corrected molar ratios with N6 and N7 (table 10) were within one standard deviation of the mean from the 31 isolates evaluated individually. The H4 and N7 subtype-specific amplifications produced multiple amplicons with a larger contribution of these additional products to total molarity observed for H4. The H4:N6 corrected ratio was outside one standard deviation of ratios obtained for H4:N6 isolates evaluated in isolation. The corrected ratio for Figure 3 . Electropherograms of hemagglutinin and neuraminidase subtypes from a mixed sample containing two avian influenza virus HA:NA subtypes. Analytes produced from purified and characterized isolates reverse transcribed into deoxyribonucleic acid from purified ribonucleic acid, amplified by quantitative polymerase chain reaction, and then evaluated for amplicon size and molarity. Subtype identification is associated with each graph.
(HA:NA, hemagglutinin: neuraminidase; bp, base pair; FU, fluorescent unit; H, identifies hemagglutinin gene; N, identifies neuraminidase gene; IM, internal marker; TA, subtype-specific target amplicon) Figure 4 . Electropherograms of hemagglutinin and neuraminidase subtypes from a mixed sample containing two avian influenza virus HA:NA subtypes with a shared hemagglutinin subtype. Analytes produced from purified and characterized isolates reverse transcribed into deoxyribonucleic acic from purified ribonucleic acid, amplified by quantitative polymerase chain reaction, and then evaluated for amplicon size and molarity. Subtype identification is associated with each graph.
(HA:NA, hemagglutinin: neuraminidase; FU, fluorescent unit; H, identifies hemagglutinin gene; N, identifies neuraminidase gene; TA, subtype-specific target amplicon; IM, internal marker; bp, base pair) H4:N7 was slightly lower than the ratio obtained when this HA:NA subtype was evaluated alone (table 8) .
To evaluate the efficacy of the method as it relates to environmental samples, we spiked sediment acquired from a pond used by migratory waterfowl using intact virions of the H4:N6 subtype. Our intent here was to simulate actual methods that would be used in environmental surveillance. Analysis of amplified products for H4 and N6 revealed single products in the 100-1,000 bp range ( fig. 5 ). Amplification strengths for H4 and N6 were 1.71 and 2.19, respectively, which are consistent with amplification strength for these subtypes when evaluated directly from allantoic fluid (tables 9 and 10). Molar ratios determined for the spiked H4:N6 were 1.28 (corrected) and 1.14 (not corrected). These values are like those obtained for H4:N6 from allantoic fluid (table 8), indicating that the inclusion of an environmentally relevant substrate had little effect on analysis outcome. The identities of the H4 and N6 subtypes were confirmed by sequencing (tables 3 and 4).
As indicated in process results, the use of RT-qPCR was more effective at establishing ratios closer to the ideal value of 1, as shown by the lower ratio mean ± standard deviation values obtained from the copy count, relative to those produced using corrected molar ratios. Further, the use of amplification efficiency provides a simpler means of ratio correction for AIV RNA obtained from egg cultures.
The relatively high concentrations of RNA from other organisms obtained from direct extraction of environmental samples and the potential variation in the concentration and sequence of this RNA complicates the determination of amplification efficiency by essentially forcing an efficiency determination for each HA and NA subtype in each sample. The use of molar ratios was an attempt to circumvent this issue. Correction of molar ratios from the simple HA:NA equation was necessary because of relative differences in the observed degree of amplification (matrix effect) and because of the production of multiple non-specific products in some reactions. The requirement for determining some measure of amplification efficiency was not eliminated using molarity measures.
Our objective was to evaluate the use of molarity in AIV HA:NA subtype grouping, using robust conditions while still using purified and fully characterized isolates to facilitate methods development. Our final goal was to provide a method application for processes in which RNA extractions are performed directly from samples without intervening viral proliferation steps. The difference in sequence-confirmed target amplicon size relative to those reported by Tsukamoto and others (2012) contributed to the potential variation Table 10 . Results from a mixed sample containing two avian influenza virus HA:NA subtypes sharing a single hemagglutinin subtype. Mix produced from purified ribonucleic acid extracted from characterized isolates of avian influenza virus which was reverse transcribed into deoxyribonucleic acid, amplified by quantitative polymerase chain reaction, and then evaluated for amplicon size and molarity. Figure 5. Electropherograms of hemagglutinin and neuraminidase subtypes from pond sediment spiked with intact virus of the H4:N6 avian influenza virus subtype. Analytes produced from reverse transcribed deoxyribonucleic acid from purified virus ribonucleic acid, amplified by quantitative polymerase chain reaction, and then evaluated for amplicon size and molarity. Subtype identification is associated with each graph.
(bp, base pair; FU, fluorescent unit; H, identifies hemagglutinin gene; N, identifies neuraminidase gene; TA, subtype-specific target amplicon; IM, internal marker; bp, base pair) that was encountered. The isolates used by Tsukamoto and others (2012) were not evaluated, and a different type of qPCR instrument and different reagents were used. The reason for the observed difference in amplicon size was not determined. We can, however, point out that even when all other things are equal, there can be variation in amplicon size within a subtype (table 7) that supersedes known instrument accuracy and reproducibility tolerances. Amplicon size is directly related to molarity and thus to corrected molarity ratios. Simple HA:NA copy ratios produced from RT-qPCR and molarity can accurately associate AIV HA and NA subtypes into HA:NA groupings. Isolates from some HA:NA subtypes can yield ratios that approach the theoretically perfect value of 1.00, whereas isolates from other HA:NA subtypes consistently produce higher ratios, indicating the presence of HA:NA subtype isolate dependency. Further, the same or very similar ratios can be obtained from isolates whether they are analyzed individually or in an amalgam. The method is not perfect in that we could not account for the increase in corrected molar ratios involving the H4:N6 subtype in mixed samples. Some primer sets used in this study clearly produce amplicons besides those intended, as seen in the electropherograms and in total product molarity. The current equations (eqs. 1-3) take such products into account but do not completely compensate for their effects on the ratio outcome. Despite the imperfections, the method is sufficiently robust to be applicable to complex samples, such as pond sediment. When selecting the RT-qPCR and molarity approaches to group HA and NA subtypes into HA:NA subtypes, we recognized that the same objectives can be accomplished with next generation sequencing technologies, particularly using amplicon resequencing. Such an approach has a distinct advantage in that sequence data are generated directly, thus avoiding the need for follow-up Sanger sequencing to confirm amplicon identity. The results obtained in this study, while promising, are limited in scope and do not completely address the full spectrum of potential issues involved with the association of HA:NA subtypes. Future methods development for the identification of HA:NA subtypes would likely benefit from the inclusion of next-generation sequencing technologies to accelerate the development process and further characterize process requirements.
